Skip to main content
Top

Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer

Published in:
Title
Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
Authors
Daniel Chan
Yun Zheng
Jeffrey W. Tyner
Wee Joo Chng
Wen Wen Chien
Sigal Gery
Geraldine Leong
Glenn D. Braunstein
H. Phillip Koeffler
Publication date
01-12-2025
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 12/2025
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-025-06359-8

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images